Human Diseases Stocks List Ranked for 2024 | NYSE,

Human Diseases ETFs
Recent Human Diseases News

Symbol	Grade	Name	% Change
ITCI	A	Intra-Cellular Therapies Inc.	2.11
CMPX	B	Compass Therapeutics, Inc.	3.66
SABS	B	SAB Biotherapeutics, Inc.	19.02
TLSA	C	Tiziana Life Sciences plc	-3.87
BMRA	D	Biomerica, Inc.	0.00
LXRX	D	Lexicon Pharmaceuticals, Inc.	-37.44
DTIL	F	Precision BioSciences, Inc.	5.37
MRVI	F	Maravai LifeSciences Holdings, Inc.	0.67
FONR	F	Fonar Corporation	0.39
LCTX	F	Lineage Cell Therapeutics, Inc.	-1.86

View As Page of Charts

Related ETFs - A few ETFs which own one or more of the above listed Human Diseases stocks.

Symbol	Grade	Name	Weight
PSIL	B	AdvisorShares Psychedelics ETF	3.89
IBRN	B	iShares Neuroscience and Healthcare ETF	3.71
XPH	B	SPDR S&P Pharmaceuticals ETF	3.49
FBT	A	First Trust Amex Biotech Index Fund	3.41
BBP	A	BioShares Biotechnology Products Fund	3.13

View all Human Diseases ETFs...

Compare ETFs

Compare IBRN to XPH Compare PSIL to FBT Compare PSIL to IBRN

Human Diseases Stocks Recent News

Date	Stock	Title
Nov 1	LXRX	Sector Update: Health Care Stocks Rise Late Afternoon
Nov 1	LXRX	Top Midday Decliners
Nov 1	TLSA	Tiziana Life Sciences to Participate in BIO-Europe 2024 to Discuss Recent Clinical Advancements, Including Positive GLP-1 Combination Study Data
Nov 1	DTIL	Precision BioSciences Q3 2024 Earnings Preview
Nov 1	LXRX	Why Charter Communications Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket
Nov 1	ITCI	Intra-Cellular Therapies Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Nov 1	DTIL	Precision BioSciences (DTIL) Surges 6.1%: Is This an Indication of Further Gains?
Oct 31	LXRX	Lexicon Announces Outcome of FDA Advisory Committee for Zynquista™ (sotagliflozin) as an Adjunct to Insulin Therapy for Glycemic Control in Adults with Type 1 Diabetes and Chronic Kidney Disease
Oct 31	LXRX	Lexicon's sotagliflozin fails to win support of FDA AdComm for diabetes (update)
Oct 31	SABS	SAB BIO CEO to Participate in Fireside Chat at Guggenheim Securities Healthcare Innovation Conference
Oct 31	ITCI	Intra-Cellular Therapies Inc (ITCI) Q3 2024 Earnings Call Highlights: Robust Sales Growth and ...
Oct 31	TLSA	Tiziana Life Sciences Announces Registered Direct Offering of up to approximately $10 Million
Oct 30	ITCI	Intra-Cellular Therapies, Inc. (ITCI) Q3 2024 Earnings Call Transcript
Oct 30	ITCI	Intra-Cellular jumps on Q3 beat as Caplyta outlook brightens
Oct 30	ITCI	ITCI Q3 Loss Wider Than Expected, Revenues Top on Higher Caplyta Sales
Oct 30	ITCI	Intra-Cellular Therapies (ITCI) Reports Q3 Loss, Tops Revenue Estimates
Oct 30	TLSA	Tiziana Life Sciences Announces Positive Results from Ozempic and Nasal Anti-CD3 Combination Study
Oct 30	ITCI	Intra-Cellular: Q3 Earnings Snapshot
Oct 30	ITCI	Intra-Cellular Therapies GAAP EPS of -$0.25 misses by $0.04, revenue of $175.4M beats by $3.05M
Oct 30	ITCI	Intra-Cellular Therapies Reports Third Quarter 2024 Financial Results, Provides Corporate Update and Raises 2024 Caplyta Sales Guidance

Human Diseases: Human diseases are illnesses or conditions that affect the functioning of the human body. They can be caused by a variety of factors, including viruses, bacteria, parasites, environmental factors, genetic predisposition, or a combination of these. Common human diseases include influenza, HIV/AIDS, cancer, diabetes, and heart disease.

Browse All Tags